These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34905657)

  • 21. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.
    Guimarães TR; Swanson E; Kofler J; Thathiah A
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):942-957. PubMed ID: 34164834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
    Li C; Götz J
    J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.
    Roy J; Tsui KC; Ng J; Fung ML; Lim LW
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
    Hurtado DE; Molina-Porcel L; Carroll JC; Macdonald C; Aboagye AK; Trojanowski JQ; Lee VM
    J Neurosci; 2012 May; 32(21):7392-402. PubMed ID: 22623685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
    Provias J; Jeynes B
    Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
    Brici D; Götz J; Nisbet RM
    J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
    Wang H; Liu X; Chen S; Ye K
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of cholesterol in Alzheimer's neuro-pathogenesis].
    Biondi E
    Riv Biol; 2006; 99(2):210-5. PubMed ID: 17115369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
    Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical analysis of the 'amyloid cascade hypothesis'.
    Armstrong RA
    Folia Neuropathol; 2014; 52(3):211-25. PubMed ID: 25310732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease.
    Saroja SR; Sharma A; Hof PR; Pereira AC
    Alzheimers Dement; 2022 Sep; 18(9):1602-1615. PubMed ID: 34873815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
    Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
    Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 38. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer's disease.
    Morshed N; Lee MJ; Rodriguez FH; Lauffenburger DA; Mastroeni D; White FM
    Nat Aging; 2021 Jun; 1(6):550-565. PubMed ID: 37117831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models of Alzheimer's disease: a quest for plaques and tangles.
    Richardson JA; Burns DK
    ILAR J; 2002; 43(2):89-99. PubMed ID: 11917160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.